The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
Open accessAbstract
Glioblastoma (GBM) is the most lethal primary adult brain tumor and its pathology is hallmarked by distorted neovascularization, diffuse tumor-associated macrophage infiltration, and potent immunosuppression. Reconstituting organotypic tumor angiogenesis models with biomimetic cell heterogeneity and interactions, pro-/anti-inflammatory milieu and extracellular matrix (ECM) mechanics is critical for preclinical anti-angiogenic therapeutic screening. However, current in vitro systems do not accurately mirror in vivo human brain tumor microenvironment. Here, we engineered a three-dimensional (3D), microfluidic angiogenesis model with controllable and biomimetic immunosuppressive conditions, immune-vascular and cell-matrix interactions. We demonstrate in vitro, GL261 and CT-2A GBM-like tumors steer macrophage polarization towards a M2-like phenotype for fostering an immunosuppressive and proangiogenic niche, which is consistent with human brain tumors. We distinguished that GBM and M2-like immunosuppressive macrophages promote angiogenesis, while M1-like pro-inflammatory macrophages suppress angiogenesis, which we coin “inflammation-driven angiogenesis.” We observed soluble immunosuppressive cytokines, predominantly TGF-β1, and surface integrin (αvβ3) endothelial-macrophage interactions are required in inflammation-driven angiogenesis. We demonstrated tuning cell-adhesion receptors using an integrin (αvβ3)-specific collagen hydrogel regulated inflammation-driven angiogenesis through Src-PI3K-YAP signaling, highlighting the importance of altered cell-ECM interactions in inflammation. To validate the preclinical applications of our 3D organoid model and mechanistic findings of inflammation-driven angiogenesis, we screened a novel dual integrin (αvβ3) and cytokine receptor (TGFβ-R1) blockade that suppresses GBM tumor neovascularization by simultaneously targeting macrophage-associated immunosuppression, endothelial-macrophage interactions, and altered ECM. Hence, we provide an interactive and controllable GBM tumor microenvironment and highlight the importance of macrophage-associated immunosuppression in GBM angiogenesis, paving a new direction of screening novel anti-angiogenic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 1×
“YAP, a transcriptional coactivator in the Hippo pathway, has recently been investigated in endothelial [47] and tumor cells [48], and has been shown to be regulated by nucleocytoplasmic shuttling in a phosphorylation-dependent manner [49].”
The role of microglia and macrophages in glioma maintenance and progression
Hambardzumyan, D., Gutmann, D. H., & Kettenmann, H. (2016) · Nature Neuroscience · doi:10.1038/nn.4185 · Cited by 1,683
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241 · cited 1×
“Indeed, in vivo TAMs are predominantly shifted towards the M2 phenotype by surrounding anti-inflammatory cytokines such as IL-10 [41] and TGF-b [42], contributing to suppressed immune surveillance and enhanced tumor angiogenesis, invasion, and metastasis [43].”
Fantin, A., Vieira, J. M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S. W., & Ruhrberg, C. (2010) · Blood · doi:10.1182/blood-2009-12-257832 · Cited by 1,153 · cited 3×
“Previous studies demonstrate increasing numbers of TAMs being proximal or in physical contact with tumor vasculature, implicating perivascular macrophage-EC interactions may regulate tumor angiogenesis [21,22].”
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940 · cited 1×
“Furthermore, macrophages can degrade the ECM by producing proteases, such as metalloproteinase-9 (MMP-9), MMP-2, MMP-3, and excavating routes for EC proliferation and migration, and indirectly promoting angiogenic invasion and sprout formation [58].”
In vitro microvessels for the study of angiogenesis and thrombosis
Zheng, Y., Chen, J., Craven, M., Choi, N. W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., López, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201240109 · Cited by 894
Tumor-associated macrophages: from basic research to clinical application
Yang, L., & Zhang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0430-2 · Cited by 847
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Jetten, N., Verbruggen, S., Gijbels, M. J., Post, M. J., De Winther, M. P. J., & Donners, M. M. P. C. (2014) · Angiogenesis · doi:10.1007/s10456-013-9381-6 · Cited by 839
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T., Perry, J. R., & Wick, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 771
Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
Vasudev, N. S., & Reynolds, A. R. (2014) · Angiogenesis · doi:10.1007/s10456-014-9420-y · Cited by 738
Making a tumour's bed: glioblastoma stem cells and the vascular niche
Gilbertson, R. J., & Rich, J. N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2246 · Cited by 715
The Hippo signaling pathway in stem cell biology and cancer
Mo, J., Park, H. W., & Guan, K. (2014) · EMBO reports · doi:10.15252/embr.201438638 · Cited by 674
Targeting the TGFβ pathway for cancer therapy
Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., & de Gramont, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 611
Thrombospondin‐1 as an endogenous inhibitor of angiogenesis and tumor growth
Lawler, J. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00307.x · Cited by 540
Glioblastoma: defining tumor niches
Hambardzumyan, D., & Bergers, G. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.009 · Cited by 522
Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Nguyen, D.-H. T., Stapleton, S. C., Yang, M. T., Cha, S. S., Choi, C. K., Galie, P. A., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221526110 · Cited by 493
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
Motz, G. T., & Coukos, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3064 · Cited by 481
Organotypic brain slice cultures: A review
Humpel, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.086 · Cited by 480
TGFβ signaling plays a critical role in promoting alternative macrophage activation
Gong, D., Shi, W., Yi, S.-J., Chen, H., Groffen, J., & Heisterkamp, N. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-31 · Cited by 420
The mechanisms and dynamics of αvβ3 integrin clustering in living cells
Cluzel, C., Saltel, F., Lussi, J., Paulhe, F., Imhof, B. A., & Wehrle-Haller, B. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503017 · Cited by 351
Ferrari, G., Cook, B. D., Terushkin, V., Pintucci, G., & Mignatti, P. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21706 · Cited by 340
Interaction of tumor cells with the microenvironment
Ungefroren, H., Sebens, S., Seidl, D., Lehnert, H., & Hass, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-18 · Cited by 333
v Integrins in Angiogenesis and Cancer
Weis, S. M., & Cheresh, D. A. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006478 · Cited by 311
Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells
Sun, Y., Yong, K. M. A., Villa-Diaz, L. G., Zhang, X., Chen, W., Philson, R., Weng, S., Xu, H., Krebsbach, P. H., & Fu, J. (2014) · Nature Materials · doi:10.1038/nmat3945 · Cited by 259
Self-citationCooperation between integrin ανβ3 and VEGFR2 in angiogenesis
Somanath, P. R., Malinin, N. L., & Byzova, T. V. (2009) · Angiogenesis · doi:10.1007/s10456-009-9141-9 · Cited by 254
Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2
Choi, H.-J., Zhang, H., Park, H., Choi, K.-S., Lee, H.-W., Agrawal, V., Kim, Y.-M., & Kwon, Y.-G. (2015) · Nature Communications · doi:10.1038/ncomms7943 · Cited by 245
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche
Shao, Y., Taniguchi, K., Gurdziel, K., Townshend, R. F., Xue, X., Yong, K. M. A., Sang, J., Spence, J. R., Gumucio, D. L., & Fu, J. (2017) · Nature Materials · doi:10.1038/nmat4829 · Cited by 236
Lu-Emerson, C., Snuderl, M., Kirkpatrick, N. D., Goveia, J., Davidson, C., Huang, Y., Riedemann, L., Taylor, J., Ivy, P., Duda, D. G., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not082 · Cited by 226
Self-citationRibatti, D., & Crivellato, E. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00810.x · Cited by 214
di Tomaso, E., Snuderl, M., Kamoun, W. S., Duda, D. G., Auluck, P. K., Fazlollahi, L., Andronesi, O. C., Frosch, M. P., Wen, P. Y., Plotkin, S. R., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2602 · Cited by 199
Self-citationTGF-β signaling and its targeting for glioma treatment.
Han, J., Alvarez-Breckenridge, C. A., Wang, Q., & Yu, J. (2015) · PubMed · Cited by 198
Schnell, O., Krebs, B., Wagner, E., Romagna, A., Beer, A. J., Grau, S. J., Thon, N., Goetz, C., Kretzschmar, H. A., Tonn, J., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00137.x · Cited by 177
Krstic, J., & Santibanez, J. F. (2014) · The Scientific World Journal · doi:10.1155/2014/521754 · Cited by 174
Inflammation-induced interstitial migration of effector CD4+ T cells is dependent on integrin αV
Overstreet, M. G., Gaylo, A., Angermann, B. R., Hughson, A., Hyun, Y.-M., Lambert, K., Acharya, M., Billroth-MacLurg, A. C., Rosenberg, A. F., Topham, D. J., et al. (2013) · Nature Immunology · doi:10.1038/ni.2682 · Cited by 161
Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
Jackson, C. M., Ruzevick, J., Phallen, J. A., Belcaid, Z., & Lim, M. K. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/732413 · Cited by 157
Sun, J.-L., Jiao, K., Niu, L., Jiao, Y., Song, Q., Shen, L.-J., Tay, F. R., & Chen, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.050 · Cited by 148
Engineering strategies to mimic the glioblastoma microenvironment
Rape, A. D., Ananthanarayanan, B., & Kumar, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.012 · Cited by 143
Targeting SRC in glioblastoma tumors and brain metastases: Rationale and preclinical studies
Ahluwalia, M. S., de Groot, J., Liu, W., & Gladson, C. L. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.08.014 · Cited by 139
DelNero, P. F., Lane, M. E., Verbridge, S. S., Kwee, B. J., Kermani, P., Hempstead, B. L., Stroock, A. D., & Fischbach, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.035 · Cited by 134
A Comparison of Methods for Quantifying Angiogenesis in the Matrigel Assay In Vitro
Khoo, C. P., Micklem, K., & Watt, S. M. (2011) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2011.0150 · Cited by 129
New Directions in Anti-Angiogenic Therapy for Glioblastoma
Wang, N., Jain, R. K., & Batchelor, T. T. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0510-y · Cited by 129
Rindopepimut: A Promising Immunotherapeutic for the Treatment of Glioblastoma Multiforme
Swartz, A. M., Li, Q.-J., & Sampson, J. H. (2014) · Immunotherapy · doi:10.2217/imt.14.21 · Cited by 111
Feng, Y., Li, Q., Wu, D., Niu, Y., Yang, C., Dong, L., & Wang, C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.042 · Cited by 107
Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms
Miletić, H., Niclou, S. P., Johansson, M., & Bjerkvig, R. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902806444 · Cited by 103
Immunotherapy for the Treatment of Glioblastoma
Thomas, A. A., Ernstoff, M. S., & Fadul, C. E. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182431a73 · Cited by 97
Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells
Tian, Y. F., Ahn, H., Schneider, R. S., Yang, S. N., Lidia, R.-G., Melnick, A. M., Cerchietti, L. C. A., & Singh, A. K. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.007 · Cited by 96
In vivo animal models for studying brain metastasis: value and limitations
Daphu, I., Sundstrøm, T., Horn, S. A., Huszthy, P. C., Niclou, S. P., Sakariassen, P. Ø., Immervoll, H., Miletić, H., Bjerkvig, R., & Thorsen, F. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9566-9 · Cited by 89
Anghelina, M. I., Krishnan, P., Moldovan, L., & Moldovan, N. I. (2004) · Stem Cells and Development · doi:10.1089/scd.2004.13.665 · Cited by 83
Antiangiogenic Therapy for Glioblastoma
Gerstner, E. R., & Batchelor, T. T. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182431c6f · Cited by 79
Reardon, D. A., & Cheresh, D. (2011) · Genes & Cancer · doi:10.1177/1947601912450586 · Cited by 76 · cited 1×
“Anti-angiogenic therapy has become an important target in the treatment of many solid tumors including GBM [50].”
Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity
Ho, I. A. W., & SHIM, W. S. N. (2017) · BioMed Research International · doi:10.1155/2017/9634172 · Cited by 73
Stemness of the CT-2A Immunocompetent Mouse Brain Tumor Model: Characterization In Vitro
Binello, E., Qadeer, Z. A., Kothari, H. P., Emdad, L., & Germano, I. M. (2012) · Journal of Cancer · doi:10.7150/jca.4149 · Cited by 71
Combating Immunosuppression in Glioma
Vega, E. A., Graner, M. W., & Sampson, J. H. (2008) · Future Oncology · doi:10.2217/14796694.4.3.433 · Cited by 68
Osteoblast-derived paracrine factors regulate angiogenesis in response to mechanical stimulation
Liu, C., Cui, X., Ackermann, T. M., Flamini, V., Chen, W., & Castillo, A. B. (2016) · Integrative Biology · doi:10.1039/c6ib00070c · Cited by 48
Self-citationPositively and Negatively Modulating Cell Adhesion to Type I Collagen Via Peptide Grafting
Monteiro, G. A., Fernandes, A. V., Sundararaghavan, H. G., & Shreiber, D. I. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0346 · Cited by 41
Bayin, N. S., Ma, L., Thomas, C., Baitalmal, R., Suré, A., Fansiwala, K. M., Bustoros, M. W., Golfinos, J. G., Pacione, D. R., Snuderl, M., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.08.008 · Cited by 37
Self-citationOrganotypic Explant Culture of Glioblastoma Multiforme and Subsequent Single‐Cell Suspension
Shimizu, F., Hovinga, K. E., Metzner, M., Soulet, D., & Tabar, V. S. (2011) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc0305s19 · Cited by 27
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
The role of collagen in cancer: from bench to bedside
Xu, S., Xu, H., Wang, W., Li, S., Li, H., Li, T., Zhang, W., Yu, X., & Liu, L. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2058-1 · Cited by 735
Organ-on-a-Chip: A New Paradigm for Drug Development
Ma, C., Peng, Y., Li, H., & Chen, W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.009 · Cited by 576
Self-citationGenetically engineered cerebral organoids model brain tumor formation
Bian, S., Repic, M., Guo, Z., Kavirayani, A., Burkard, T., Bagley, J. A., Krauditsch, C., & Knoblich, J. A. (2018) · Nature Methods · doi:10.1038/s41592-018-0070-7 · Cited by 415
Lin, H., Liu, C., Hu, A., Zhang, D., Yang, H., & Mao, Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01544-7 · Cited by 392
Metadata
- Authors
- Cui, X., Morales, R.-T. T., Qian, W., Wang, H., Gagner, J.-P., Dolgalev, I., Placantonakis, D., Zagzag, D., Cimmino, L., Snuderl, M., Lam, R. H. W., & Chen, W.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 161
- Pages
- 164-178
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2794101039
- Cited by
- 267
- References
- 61
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.